Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
3 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
4 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
5 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
7 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
8 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
9 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
10 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
11 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
12 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
13 EGFR tyrosine kinase inhibitor resistance 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
14 EGFR tyrosine kinase inhibitor resistance 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
15 EGFR tyrosine kinase inhibitor resistance 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
16 EGFR tyrosine kinase inhibitor resistance 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
17 Endocytosis 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
18 Endocytosis 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
19 Endocytosis 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
20 Endocytosis 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
21 Focal adhesion 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
22 Focal adhesion 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
23 Focal adhesion 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
24 Focal adhesion 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
25 Gap junction 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
26 Gap junction 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
27 Gap junction 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
28 Gap junction 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
29 Glioma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
30 Glioma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
31 Glioma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
32 Glioma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
33 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
34 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
35 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
36 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
37 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
38 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
39 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
40 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
41 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
42 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
43 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
44 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
45 Melanoma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
46 Melanoma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
47 Melanoma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
48 Melanoma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
49 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
50 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
51 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
52 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
53 Pathways in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 Pathways in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
55 Pathways in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
56 Pathways in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
57 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
58 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
59 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
60 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
61 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
62 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
63 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
64 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
65 Prostate cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
66 Prostate cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
67 Prostate cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
68 Prostate cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
69 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
70 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
71 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
72 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
73 Ras signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
74 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
75 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
76 Ras signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
77 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
78 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
79 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
80 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬

Back to top